Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Lumora vs NiceRx

Lumora
Graded #205

Level

vs
NiceRx
Graded #208

Level

The verdict

Too close to call — both grade 66.1/100 (C).

Lumora and NiceRx land on the same WeighScore, so neither clears the other on our six graded dimensions. Lumora sits one line higher on the board (#205 vs #208) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNiceRx +18
36
54
Dose & formulationLumora +11
75
64
Clinical oversightLumora +1
87
86
Labs & monitoringLumora +23
76
53
FulfillmentNiceRx +11
74
85
Contract termsEven
55
55
Lumora · left barNiceRx · right bar

The numbers

MetricLumoraNiceRx
WeighScore66.1/10066.1/100
GradeCC
Scorecard rank#205#208
Semaglutide$199/mo (starting dose, plus a separate fee, compounded)$199/mo (compounded)
Tirzepatide$299/mo (starting dose, compounded)$299/mo (compounded)
CoverageCoverage not published46 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Lumora

Graded #205 · C

Strengths

  • Compounded semaglutide (5 dose tiers) and tirzepatide (6 dose tiers) in injectable and sublingual forms
  • Physician-founded by board-certified Drs. Sean and Shannon Arora (Arora Health & Aesthetics); clinician reviews every assessment
  • LegitScript certified, HIPAA compliant, medications dispensed through licensed U.S. pharmacy partners
  • Visit fees, medication, labs, and follow-up all included; full pricing shown before commitment
  • Peptide therapies offered including NAD+, sermorelin, glutathione, gonadorelin, and PT-141

Where it loses points

  • Pricing is fully gated behind the assessment — no public pricing; actual monthly costs unverifiable without completing intake
  • Compounded medications are not FDA-approved; compounding pharmacy partners not publicly named
  • Newer brand with 2026 founding; no Trustpilot rating or accessible public patient reviews found
  • No dietitian, coaching, or HSA/FSA eligibility disclosed on public pages
  • Claims all 50 states but 'treatment options may vary by state' with no explicit state-by-state coverage list
NiceRx

Graded #208 · C

Strengths

  • LegitScript approved
  • Named legal entity (NiceRx LLC) with Boca Raton FL address
  • First-month discount on both drugs
  • Every batch tested for sterility and potency
  • 46-state coverage

Where it loses points

  • Not available in Alaska, Mississippi, New Jersey, Kansas
  • Compounded only — no brand-name options
  • Broader platform (anti-aging, NAD+, B12)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard